Send to a Friend Font Size: Increase Decrease

Carl Icahn

Carl Icahn's Portfolio

Ticker	# of Shares	Price	Value
IEP	79,238,262	$35.70	$2,828,805,954
MSI	38,292,235	$46.40	$1,776,759,704
EP	65,983,829	$25.79	$1,701,722,950
MMI	33,505,706	$38.65	$1,294,995,537
FDML	75,980,915	$14.21	$1,079,688,803
CLX	12,039,196	$65.50	$788,567,338
FRX	26,083,088	$29.75	$775,971,868
CLX	7,098,678	$65.50	$464,963,409
CLX	6,587,378	$65.50	$431,473,259
HAIN	7,130,563	$37.99	$270,890,089
View Additional Portfolio Information »

http://www.icahnreport.com/

Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.

Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.

Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.

In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.

In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.

Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.

In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.

Login to help us fill in information about this entity.

Carl Icahn Files Q3 13F Nov 14, 2011 05:55PM

Carl Icahn Liquidates Biogen Idec (BIIB), Chesapeake Energy (CHK); Targets Oshkosh (OSK), Forest Labs (FRX) and Commercial Metals (CMC) Aug 15, 2011 06:24PM

Icahn's Icahn Capital Shows New Stake in Amgen (AMGN), Clorox (CLX) and Southern Union (NYSE: SUG); Raises Dynegy (DYN), Lowers Chesapeake (CHK) May 16, 2011 04:57PM

Icahn Hangs on to Pharmas, Makes Housing Play, Increases Lions Gate Holding in Recent 13F (MOT, MAS, HAIN, More...) Nov 15, 2010 05:39PM

Icahn Raises Stake in Enzon Pharmaceuticals (ENZN) to 7.22% Nov 10, 2010 12:38PM

Jan 29, 2009 03:43PM Icahn Boosts Stake In Enzon (ENZN) to 7.8%
Aug 14, 2008 04:44PM Icahn's Icahn Capital Bumps Stake in Motorola (MOT), Shows New Small Stake in Emisphere (EMIS)
Aug 11, 2008 08:32AM Enzon Pharma (ENZN) To Explore Options for Specialty Pharmaceuticals Business
May 20, 2008 11:53AM Enzon (ENZN) Holder DellaCamera Capital Wants Banker Hired To Explore Sale of Commercial Operations
Mar 14, 2008 12:32PM Carl Icahn Boosts Stake in Enzon Pharm (ENZN), Wants Co To Consider a Sale
Mar 14, 2008 12:27PM Icahn boosts stake in Enzon Pharmaceuticals (ENZN) from 6.93%, Wants Co To Consider Sale
Feb 14, 2008 12:22PM Summary of Icahn Capital 13F; New Stake In JCP, Ups Stakes in APC, M

Carl Icahn

Carl Icahn's Portfolio

Free News Feed